NEUCA S.A. (WSE:NEU)

Poland flag Poland · Delayed Price · Currency is PLN
701.00
+1.00 (0.14%)
May 30, 2025, 4:44 PM CET
-23.14%
Market Cap 3.14B
Revenue (ttm) 12.82B
Net Income (ttm) 146.20M
Shares Out 4.48M
EPS (ttm) 32.16
PE Ratio 21.76
Forward PE 14.06
Dividend 16.00 (2.29%)
Ex-Dividend Date Jul 15, 2025
Volume 966
Average Volume 853
Open 710.00
Previous Close 700.00
Day's Range 699.00 - 710.00
52-Week Range 636.00 - 946.00
Beta 0.56
RSI 45.05
Earnings Date May 18, 2025

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company owns and produces Rx, OTC medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brand names to pharmacists, medical doctors,... [Read more]

Sector Healthcare
Founded 1990
Employees 4,445
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NEU
Full Company Profile

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.

Financial Statements

News

There is no news available yet.